Bal Pharma Limited (IN:BALPHARMA)
:BALPHARMA
Want to see IN:BALPHARMA full AI Analyst Report?
Total Valuation
Bal Pharma Limited has a market cap or net worth of ₹1.35B. The enterprise value is ₹2.96B.
Market Cap₹1.35B
Enterprise Value₹2.96B
Share Statistics
Bal Pharma Limited has 15,920,872 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding15,920,872
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Bal Pharma Limited’s return on equity (ROE) is 0.08 and return on invested capital (ROIC) is 8.20%.
Return on Equity (ROE)0.08
Return on Assets (ROA)0.02
Return on Invested Capital (ROIC)8.20%
Return on Capital Employed (ROCE)0.16
Revenue Per Employee3.59M
Profits Per Employee72.39K
Employee Count868
Asset Turnover0.83
Inventory Turnover2.02
Valuation Ratios
The current PE Ratio of Bal Pharma Limited is 21.8. Bal Pharma Limited’s PEG ratio is -1.14.
PE Ratio21.8
PS Ratio0.31
PB Ratio1.17
Price to Fair Value1.17
Price to FCF-23.54
Price to Operating Cash Flow15.54
PEG Ratio-1.14
Income Statement
In the last 12 months, Bal Pharma Limited had revenue of 3.12B and earned 62.84M in profits. Earnings per share was 3.95.
Revenue3.12B
Gross Profit761.52M
Operating Income208.24M
Pretax Income59.34M
Net Income62.84M
EBITDA319.03M
Earnings Per Share (EPS)3.95
Cash Flow
In the last 12 months, operating cash flow was 88.16M and capital expenditures -76.88M, giving a free cash flow of 11.28M billion.
Operating Cash Flow88.16M
Free Cash Flow11.28M
Free Cash Flow per Share0.71
Dividends & Yields
Bal Pharma Limited pays an annual dividend of ₹1.2, resulting in a dividend yield of 1.62%
Dividend Per Share₹1.2
Dividend Yield1.62%
Payout Ratio23.51%
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.83
52-Week Price Change-14.95%
50-Day Moving Average79.61
200-Day Moving Average77.81
Relative Strength Index (RSI)54.54
Average Volume (3m)4.08K
Important Dates
Bal Pharma Limited upcoming earnings date is Aug 6, 2026, TBA (Confirmed).
Last Earnings DateMay 27, 2026
Next Earnings DateAug 6, 2026
Ex-Dividend Date―
Financial Position
Bal Pharma Limited as a current ratio of 1.05, with Debt / Equity ratio of 193.99%
Current Ratio1.05
Quick Ratio0.59
Debt to Market Cap1.66
Net Debt to EBITDA4.77
Interest Coverage Ratio1.24
Taxes
In the past 12 months, Bal Pharma Limited has paid -3.86M in taxes.
Income Tax-3.86M
Effective Tax Rate-0.07
Enterprise Valuation
Bal Pharma Limited EV to EBITDA ratio is 7.79, with an EV/FCF ratio of -60.84.
EV to Sales0.80
EV to EBITDA7.79
EV to Free Cash Flow-60.84
EV to Operating Cash Flow17.17
Balance Sheet
Bal Pharma Limited has ₹105.19M in cash and marketable securities with ₹0.00 in debt, giving a net cash position of ₹105.19M billion.
Cash & Marketable Securities₹105.19M
Total Debt₹0.00
Net Cash₹105.19M
Net Cash Per Share₹6.61
Tangible Book Value Per Share₹40.86
Margins
Gross margin is 35.94%, with operating margin of 6.68%, and net profit margin of 2.02%.
Gross Margin35.94%
Operating Margin6.68%
Pretax Margin1.90%
Net Profit Margin2.02%
EBITDA Margin10.24%
EBIT Margin6.68%
Analyst Forecast
The average price target for Bal Pharma Limited is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast2.83%
EPS Growth Forecast-26.18%